Seneca Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$530K Hold
1,505
0.16% 40
2025
Q4
$493K Sell
1,505
-62
-4% -$19.7K 0.15% 41
2025
Q3
$442K Hold
1,567
0.14% 40
2025
Q2
$438K Hold
1,567
0.17% 40
2025
Q1
$488K Hold
1,567
0.24% 37
2024
Q4
$408K Sell
1,567
-160
-9% -$47.5K 0.2% 37
2024
Q3
$556K Hold
1,727
0.27% 36
2024
Q2
$540K Hold
1,727
0.28% 39
2024
Q1
$491K Hold
1,727
0.26% 40
2023
Q4
$497K Hold
1,727
0.29% 38
2023
Q3
$464K Hold
1,727
0.32% 37
2023
Q2
$383K Hold
1,727
0.25% 38
2023
Q1
$418K Buy
1,727
+62
+4% +$15.2K 0.27% 37
2022
Q4
$437K Hold
1,665
0.28% 31
2022
Q3
$375K Sell
1,665
-27
-2% -$6.54K 0.27% 33
2022
Q2
$412K Hold
1,692
0.28% 32
2022
Q1
$409K Hold
1,692
0.25% 33
2021
Q4
$381K Hold
1,692
0.23% 35
2021
Q3
$360K Buy
1,692
+5
+0.3% +$1.15K 0.24% 30
2021
Q2
$411K Hold
1,687
0.27% 31
2021
Q1
$420K Hold
1,687
0.3% 29
2020
Q4
$388K Buy
+1,687
New +$389K 0.29% 30

Other funds holding AMGN

Seneca Financial Advisors's AMGN Position: Q1 2026 in Review

Seneca Financial Advisors held its Amgen (AMGN) position steady in Q1 2026 at 1,505 shares worth $530K. The position accounts for 0.16% of the portfolio, ranked #40.

Seneca Financial Advisors first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $556K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Seneca Financial Advisors held 1,505 shares of Amgen worth $530K as of Q1 2026.
  • Seneca Financial Advisors left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.16% of Seneca Financial Advisors's portfolio in Q1 2026, its #40 holding.
  • Seneca Financial Advisors first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Seneca Financial Advisors's Amgen position peaked at $556K in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Seneca Financial Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.